Report Detail
Global Vascular Biosynthetic Grafts Market Insights, Forecast to 2025
- RnM2872953 |
- 04 February, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Other
The global Vascular Biosynthetic Grafts market is valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. The objectives of this study are to define, segment, and project the size of the Vascular Biosynthetic Grafts market based on company, product type, end user and key regions.
This report studies the global market size of Vascular Biosynthetic Grafts in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Vascular Biosynthetic Grafts in these regions.
This research report categorizes the global Vascular Biosynthetic Grafts market by top players/brands, region, type and end user. This report also studies the global Vascular Biosynthetic Grafts market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
B. Braun (Germany)
C. R. Bard (US)
Cardinal Health (US)
Cook Medical (US)
Endologix (US)
LeMaitre Vascular (US)
Medtronic (Ireland)
Maquet (Germany)
Terumo (Japan)
Gore Medical (US)
Market size by Product
Endovascular Aneurysm Repair
Peripheral Vascular
Hemodialysis Access
Market size by End User
Hospitals
Ambulatory Surgical Centers
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Vascular Biosynthetic Grafts market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Vascular Biosynthetic Grafts market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Vascular Biosynthetic Grafts companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Vascular Biosynthetic Grafts submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Vascular Biosynthetic Grafts are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Vascular Biosynthetic Grafts market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Vascular Biosynthetic Grafts Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Vascular Biosynthetic Grafts Market Size Growth Rate by Product
- 1.4.2 Endovascular Aneurysm Repair
- 1.4.3 Peripheral Vascular
- 1.4.4 Hemodialysis Access
- 1.5 Market by End User
- 1.5.1 Global Vascular Biosynthetic Grafts Market Size Growth Rate by End User
- 1.5.2 Hospitals
- 1.5.3 Ambulatory Surgical Centers
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Vascular Biosynthetic Grafts Market Size
- 2.1.1 Global Vascular Biosynthetic Grafts Revenue 2014-2025
- 2.1.2 Global Vascular Biosynthetic Grafts Sales 2014-2025
- 2.2 Vascular Biosynthetic Grafts Growth Rate by Regions
- 2.2.1 Global Vascular Biosynthetic Grafts Sales by Regions
- 2.2.2 Global Vascular Biosynthetic Grafts Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Vascular Biosynthetic Grafts Sales by Manufacturers
- 3.1.1 Vascular Biosynthetic Grafts Sales by Manufacturers
- 3.1.2 Vascular Biosynthetic Grafts Sales Market Share by Manufacturers
- 3.1.3 Global Vascular Biosynthetic Grafts Market Concentration Ratio (CR5 and HHI)
- 3.2 Vascular Biosynthetic Grafts Revenue by Manufacturers
- 3.2.1 Vascular Biosynthetic Grafts Revenue by Manufacturers (2014-2019)
- 3.2.2 Vascular Biosynthetic Grafts Revenue Share by Manufacturers (2014-2019)
- 3.3 Vascular Biosynthetic Grafts Price by Manufacturers
- 3.4 Vascular Biosynthetic Grafts Manufacturing Base Distribution, Product Types
- 3.4.1 Vascular Biosynthetic Grafts Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Vascular Biosynthetic Grafts Product Type
- 3.4.3 Date of International Manufacturers Enter into Vascular Biosynthetic Grafts Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Vascular Biosynthetic Grafts Sales by Product
- 4.2 Global Vascular Biosynthetic Grafts Revenue by Product
- 4.3 Vascular Biosynthetic Grafts Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Vascular Biosynthetic Grafts Breakdown Data by End User
6 North America
- 6.1 North America Vascular Biosynthetic Grafts by Countries
- 6.1.1 North America Vascular Biosynthetic Grafts Sales by Countries
- 6.1.2 North America Vascular Biosynthetic Grafts Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Vascular Biosynthetic Grafts by Product
- 6.3 North America Vascular Biosynthetic Grafts by End User
7 Europe
- 7.1 Europe Vascular Biosynthetic Grafts by Countries
- 7.1.1 Europe Vascular Biosynthetic Grafts Sales by Countries
- 7.1.2 Europe Vascular Biosynthetic Grafts Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Vascular Biosynthetic Grafts by Product
- 7.3 Europe Vascular Biosynthetic Grafts by End User
8 Asia Pacific
- 8.1 Asia Pacific Vascular Biosynthetic Grafts by Countries
- 8.1.1 Asia Pacific Vascular Biosynthetic Grafts Sales by Countries
- 8.1.2 Asia Pacific Vascular Biosynthetic Grafts Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Vascular Biosynthetic Grafts by Product
- 8.3 Asia Pacific Vascular Biosynthetic Grafts by End User
9 Central & South America
- 9.1 Central & South America Vascular Biosynthetic Grafts by Countries
- 9.1.1 Central & South America Vascular Biosynthetic Grafts Sales by Countries
- 9.1.2 Central & South America Vascular Biosynthetic Grafts Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Vascular Biosynthetic Grafts by Product
- 9.3 Central & South America Vascular Biosynthetic Grafts by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Vascular Biosynthetic Grafts by Countries
- 10.1.1 Middle East and Africa Vascular Biosynthetic Grafts Sales by Countries
- 10.1.2 Middle East and Africa Vascular Biosynthetic Grafts Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Vascular Biosynthetic Grafts by Product
- 10.3 Middle East and Africa Vascular Biosynthetic Grafts by End User
11 Company Profiles
- 11.1 B. Braun (Germany)
- 11.1.1 B. Braun (Germany) Company Details
- 11.1.2 Company Business Overview
- 11.1.3 B. Braun (Germany) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 B. Braun (Germany) Vascular Biosynthetic Grafts Products Offered
- 11.1.5 B. Braun (Germany) Recent Development
- 11.2 C. R. Bard (US)
- 11.2.1 C. R. Bard (US) Company Details
- 11.2.2 Company Business Overview
- 11.2.3 C. R. Bard (US) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 C. R. Bard (US) Vascular Biosynthetic Grafts Products Offered
- 11.2.5 C. R. Bard (US) Recent Development
- 11.3 Cardinal Health (US)
- 11.3.1 Cardinal Health (US) Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Cardinal Health (US) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Cardinal Health (US) Vascular Biosynthetic Grafts Products Offered
- 11.3.5 Cardinal Health (US) Recent Development
- 11.4 Cook Medical (US)
- 11.4.1 Cook Medical (US) Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Cook Medical (US) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Cook Medical (US) Vascular Biosynthetic Grafts Products Offered
- 11.4.5 Cook Medical (US) Recent Development
- 11.5 Endologix (US)
- 11.5.1 Endologix (US) Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Endologix (US) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Endologix (US) Vascular Biosynthetic Grafts Products Offered
- 11.5.5 Endologix (US) Recent Development
- 11.6 LeMaitre Vascular (US)
- 11.6.1 LeMaitre Vascular (US) Company Details
- 11.6.2 Company Business Overview
- 11.6.3 LeMaitre Vascular (US) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 LeMaitre Vascular (US) Vascular Biosynthetic Grafts Products Offered
- 11.6.5 LeMaitre Vascular (US) Recent Development
- 11.7 Medtronic (Ireland)
- 11.7.1 Medtronic (Ireland) Company Details
- 11.7.2 Company Business Overview
- 11.7.3 Medtronic (Ireland) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 Medtronic (Ireland) Vascular Biosynthetic Grafts Products Offered
- 11.7.5 Medtronic (Ireland) Recent Development
- 11.8 Maquet (Germany)
- 11.8.1 Maquet (Germany) Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Maquet (Germany) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Maquet (Germany) Vascular Biosynthetic Grafts Products Offered
- 11.8.5 Maquet (Germany) Recent Development
- 11.9 Terumo (Japan)
- 11.9.1 Terumo (Japan) Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Terumo (Japan) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Terumo (Japan) Vascular Biosynthetic Grafts Products Offered
- 11.9.5 Terumo (Japan) Recent Development
- 11.10 Gore Medical (US)
- 11.10.1 Gore Medical (US) Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Gore Medical (US) Vascular Biosynthetic Grafts Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Gore Medical (US) Vascular Biosynthetic Grafts Products Offered
- 11.10.5 Gore Medical (US) Recent Development
12 Future Forecast
- 12.1 Vascular Biosynthetic Grafts Market Forecast by Regions
- 12.1.1 Global Vascular Biosynthetic Grafts Sales Forecast by Regions 2019-2025
- 12.1.2 Global Vascular Biosynthetic Grafts Revenue Forecast by Regions 2019-2025
- 12.2 Vascular Biosynthetic Grafts Market Forecast by Product
- 12.2.1 Global Vascular Biosynthetic Grafts Sales Forecast by Product 2019-2025
- 12.2.2 Global Vascular Biosynthetic Grafts Revenue Forecast by Product 2019-2025
- 12.3 Vascular Biosynthetic Grafts Market Forecast by End User
- 12.4 North America Vascular Biosynthetic Grafts Forecast
- 12.5 Europe Vascular Biosynthetic Grafts Forecast
- 12.6 Asia Pacific Vascular Biosynthetic Grafts Forecast
- 12.7 Central & South America Vascular Biosynthetic Grafts Forecast
- 12.8 Middle East and Africa Vascular Biosynthetic Grafts Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Vascular Biosynthetic Grafts Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Vascular Biosynthetic Grafts . Industry analysis & Market Report on Vascular Biosynthetic Grafts is a syndicated market report, published as Global Vascular Biosynthetic Grafts Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Vascular Biosynthetic Grafts market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
